$555 Million is the total value of SECTOR GAMMA AS's 30 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABT | Buy | ABBOTT LABS | $66,250,000 | +7.5% | 1,105,642 | +2.4% | 11.94% | +15.3% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $47,575,000 | +12.8% | 1,741,380 | +2.4% | 8.57% | +21.0% |
| BAX | Buy | BAXTER INTL INC | $46,532,000 | +3.7% | 715,438 | +3.0% | 8.39% | +11.1% |
| MRK | Buy | MERCK & CO INC | $39,502,000 | +25.7% | 725,200 | +29.8% | 7.12% | +34.8% |
| PKI | Sell | PERKINELMER INC | $28,638,000 | -11.2% | 378,206 | -14.2% | 5.16% | -4.7% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $28,187,000 | -9.4% | 806,035 | -10.1% | 5.08% | -2.9% |
| SHPG | Buy | SHIRE PLCsponsored adr | $24,646,000 | +136.9% | 164,975 | +146.0% | 4.44% | +154.0% |
| BIO | Sell | BIO RAD LABS INCcl a | $23,568,000 | +3.9% | 94,240 | -0.8% | 4.25% | +11.4% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $22,897,000 | -3.0% | 362,006 | -6.0% | 4.13% | +4.1% |
| IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $21,415,000 | -11.7% | 386,966 | -23.6% | 3.86% | -5.3% |
| LLY | Buy | LILLY ELI & CO | $19,537,000 | +50.8% | 252,514 | +64.6% | 3.52% | +61.7% |
| NUVA | Buy | NUVASIVE INC | $19,422,000 | +27.6% | 371,997 | +43.0% | 3.50% | +36.8% |
| ANTM | Sell | ANTHEM INC | $18,874,000 | -30.9% | 85,910 | -29.2% | 3.40% | -25.9% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $17,299,000 | -2.9% | 1,121,135 | -5.7% | 3.12% | +4.1% |
| CAH | New | CARDINAL HEALTH INC | $14,182,000 | – | 226,263 | +100.0% | 2.56% | – |
| LH | Buy | LABORATORY CORP AMER HLDGS | $13,652,000 | +7.0% | 84,400 | +5.5% | 2.46% | +14.7% |
| THC | Buy | TENET HEALTHCARE CORP | $12,950,000 | +83.5% | 534,021 | +14.7% | 2.33% | +96.6% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $12,056,000 | +285.9% | 273,500 | +340.4% | 2.17% | +313.9% |
| PRGO | Sell | PERRIGO CO PLC | $11,488,000 | -47.2% | 137,840 | -44.8% | 2.07% | -43.4% |
| AGN | Buy | ALLERGAN PLC | $10,821,000 | +5.7% | 64,300 | +2.7% | 1.95% | +13.3% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $10,298,000 | – | 86,973 | +100.0% | 1.86% | – |
| GILD | Sell | GILEAD SCIENCES INC | $7,803,000 | -69.6% | 103,500 | -71.1% | 1.41% | -67.4% |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $7,324,000 | -11.4% | 854,592 | +2.1% | 1.32% | -5.0% |
| PDCO | Buy | PATTERSON COMPANIES INC | $6,941,000 | -36.6% | 312,232 | +3.0% | 1.25% | -32.0% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $6,541,000 | -36.3% | 123,892 | -17.9% | 1.18% | -31.7% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $4,403,000 | +80.9% | 134,800 | +169.6% | 0.79% | +94.1% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $3,779,000 | – | 51,006 | +100.0% | 0.68% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $3,353,000 | – | 41,000 | +100.0% | 0.60% | – |
| ONCE | Sell | SPARK THERAPEUTICS INC | $3,103,000 | +14.9% | 46,600 | -11.2% | 0.56% | +23.1% |
| SGMO | New | SANGAMO THERAPEUTICS INC | $1,824,000 | – | 96,000 | +100.0% | 0.33% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -9,400 | -100.0% | -0.20% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -52,173 | -100.0% | -0.28% | – |
| JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -43,400 | -100.0% | -0.33% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -275,024 | -100.0% | -0.64% | – |
| MYL | Exit | MYLAN N V | $0 | – | -131,361 | -100.0% | -0.93% | – |
| SRCL | Exit | STERICYCLE INC | $0 | – | -81,800 | -100.0% | -0.94% | – |
| DVA | Exit | DAVITA INC | $0 | – | -86,680 | -100.0% | -1.05% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -273,312 | -100.0% | -1.63% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -67,315 | -100.0% | -1.76% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -73,170 | -100.0% | -2.50% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -65,800 | -100.0% | -3.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.